A032302 Docetaxel Addition in mCRPC (ASPIRE)

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
Protocol A032302 Docetaxel Addition in Metastatic Castrate-Sensitive Prostate Cancer (ASPIRE)
Principal Investigator
Headshot of Hannah Dzimitrowicz McManus
Assistant Professor of Medicine
Protocol Number
IRB: PRO00119563
NCT: NCT06931340
Phase
Phase III
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL